New insights into the pathogenesis of interstitial nephritis

Current Opinion in Nephrology and Hypertension

Volumn 8, Issue 3, 1999, Pages 287-292

  Meyers, Catherine M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; CHEMOKINE; ENDOTHELIN 1; GAMMA INTERFERON; KIDNEY ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OSTEOPONTIN; PROTEIN; RANTES; TAMM HORSFALL GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; DISEASE COURSE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INTERSTITIAL NEPHRITIS; LYMPHOCYTE ACTIVATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; REVIEW; T LYMPHOCYTE ACTIVATION;

ANGIOTENSIN II; ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CHEMOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERFERON TYPE II; KIDNEY TUBULES; NEPHRITIS, INTERSTITIAL; NITRIC OXIDE; PROTEINURIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032789730     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199905000-00003     Document Type: Review

References (40)

1. Michel DM, Kelly CJ. Acute interstitial nephritis. J Am Soc Nephrol 1998; 9:506-515. A detailed review of acute interstitial nephritis.
2. Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990; 37:100-109.
3. Main IW, Nikolic-Paterson DJ, Atkins RC. T cells and macrophages and their role in renal injury. Semin Nephrol 1992; 12:395-407.
4. Markovic-Lipkovski J, Muller CA, Risler T, Bohle A, Muller GA. Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis. Nephrol Dial Transplant 1990; 5:10-17.
5. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20:1-17.
6. Kelly CJ. T cell regulation of autoimmune interstitial nephritis, J Am Soc Nephrol 1990; 1:140-149.
7. Kelly CJ, Roth DA, Meyers CM. Immune recognition and response to the renal interstitium. Kidney Int 1991; 31:518-530.
8. Thomas SE, Andoh TF, Pichler RH, Shankland S, Couser WG, Bennet WM, Johnson RJ. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 1998; 53:897-908. An interesting study that examines the modulatory roles of both angiotensin II and NO in a model of progressive interstitial inflammation and injury.
9. Moore KJ, Wada T, Barbee SD, Kelley VR. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fasf(lpr) mice. Kidney Int 1998; 53:1631-1641. An excellent paper that relates a newly designed technique for adoptively transferring and characterizing interstitial and glomerular lesions in experimental renal disease.
10. Meyers CM, Tomaszweski JE, Glass JD, Chen CW. The nephritogenic T cell response in murine chronic graft-vs-host disease. J Immunol 1998; 161:5321-5330. A recent characterization of nephritogenic T cell clones, derived from the kidneys of animals with autoimmune glomerutonephritis, which induce interstitial inflammation and damage.
11. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9:1213-1224. Important observations concerning the ability of states of marked proteinuria to induce interstitial inflammation and damage.
12. Moriyama T, Kawada N, Akagi Y, Ando A, Horio M, Yamanchi A et al. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephropathy. Kidney Int 1997; 63:S232-235. A concise report relating the effects of angiotensin II type I inhibition on interstitial injury in unilateral ureteral obstruction.
13. + T cell line that mediates murine interstitial nephritis. J Clin Invest 1991; 88:408-416.
14. Madaio MP. B cells and autoantibodies in the pathogenesis of lupus nephritis. Immunol Res 1998; 17:123-132. An excellent review describing the pathogenic role of humoral immune responses in interstitial, glomerular, and vascular injury observed in lupus nephritis.
15. Sclomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity, J Exp Med 1994; 180:1295-1306.
16. Pham K, Smoyer WE, Archer DC, Gabbai F, Kelly CJ. Oral feeding of renal tubular antigen abrogates interstitial nephritis and renal failure in Brown Norway rats. Kidney Int 1997; 52:725-732. An important study describing the disease-protective effects of antigen feeding on autoimmune T cell-mediated interstitial disease.
17. Chen Y, Kuchroo VK, Inobe J. Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265:1237-1240.
18. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β, J Immunol 1991;146:3012-3017.
19. 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A 1991; 88:2918-2921.
20. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90:1-7.
21. 1, on nephritogenic T cells.
22. 1. Suppression of a nephritogenic murine T cell clone. Kidney Int 1994; 46:1295-1301.
23. + T cell responses mediated by TGF-β, despite expression of early activation markers and cytokine genes. Lupus 1998; 7:56.
24. + Th2 cells. The role of PKA activation. J Am Soc Nephrol 1998; 9:462.
25. Meyers CM. T-cell regulation of renal immune responses. Curr Opin Nephrol Hypertens 1995; 4:270-276.
26. Meyers CM, Zhang Y. Immunomodulatory effects of IFN-γ on autoreactive nephritogenic T cell clones. Kidney Int 1999; in press. An interesting study examining the permissive effects of IFN-γ on nephritogenic T cell clones derived from mice with cGVHD.
27. Schwarting A, Moore K, Wada T, Tesch G, Yoon HJ, Kelley VR. IFN-γ limits macrophage expansion in MRL-Fasf(lpr) autoimmune interstitial nephritis: a negative regulatory pathway. J Immunol 1998; 160:4074-4081. A thought-provoking analysis of interstitial lesions in IFN-γ receptor-deficient MRL- lpr/lpr mice, suggesting that IFN-γ may have negative regulatory influences on renal inflammation in the setting of systemic autoimmunity.
28. Danoff TM. Chemokines in interstitial injury. Kidney Int 1998; 53:1807-1808.
29. Nadeau KC, Azuma H, Tilney NL. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A 1995; 92:8729-8733.
30. Lloyd C, Minto A, Dorf M, Proudfoot A, Wells T, Salant D, Gutierrez-Ramos J. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 1997; 185:1371-1380.
31. D'Amico G, Tubulo-interstitial damage in glomerular diseases: its role in the progression of the renal damage. Nephrol Dial Transplant 1998; 1:80-85. A detailed review that discusses studies of interstitial inflammation observed in the context of glomerular damage.
32. Hugo C, Shankland SJ, Pichler RH, Couser WG, Johnson RJ. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998; 53:302-311. An interesting study exploring the role of thrombospondin 1 as a marker for interstitial injury that occurs in experimental models of glomerular disease.
33. Pichler R, Giachelli C, Lombardi D, Pippin J, Gordon K, Alpers C, Schwartz S. Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin (uropontin). Am J Pathol 1994; 144:915-926.
34. Zager RA, Cotran RS, Hoyer JR, Pathologic localization of Tamm-Horsfall protein in interstitial deposits in renal disease. Lab Invest 1978; 38:52-57.
35. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135:719-733.
36. Zoja C, Donadelli R, Colleoni S, Figluizzi M, Bonazzola S, Morigi M, Remuzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 1998, 53:1608-1615. An important study that provides further suggestive evidence of the role of proteinuria in inducing tubulointerstitial inflammation and injury.
37. Wang Y, Chen J, Chen L, Tay T-C, Rangan GK, Harris DCH. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8:1537-1545.
38. Narita I, Border WA, Ketteler M. Noble NA, Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 1995; 72:17-25.
39. Merryman PF, Clancy RM, He SY, Abramson SB. Modulation of human T cell responses by nitric oxide and its derivative, s-nitrosoglutathione. Arthritis Rheum 1993; 10:1414-1420.
40. Gabbai FB, Boggiano C, Peter T, Khang S, Archer C, God DP, Kelly CJ. Inhibition of inducible nitric oxide synthase intensities injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997; 159:6266-6275. An excellent report further supporting the disease-protective role of iNOS generation in cell-mediated autoimmune responses.